Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with ...

Retrieved on: 2024-12-14 15:45:02

Tags for this article:

Click the tags to see associated articles and topics

Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with .... View article details on hiswai:

Excerpt

Nemluvio is the first approved monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling of IL-31.8 IL-31 is a ...

Article found on: pipelinereview.com